Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
about
Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesotheliomaGrowth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts.A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesotheliomaOverview of treatment related complications in malignant pleural mesothelioma.Prognostic nutritional index predicts postoperative complications and long-term outcomes of gastric cancer.Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry.Clinicopathologic and survival characteristics of malignant pleural mesothelioma registered in hospital cancer registryWnt7A is a putative prognostic and chemosensitivity marker in human malignant pleural mesothelioma.Clinical characteristics and treatment outcomes in 132 patients with malignant mesotheliomaLung cancer: Biology and treatment options.Folylpoly-glutamate synthetase expression is associated with tumor response and outcome from pemetrexed-based chemotherapy in malignant pleural mesotheliomaWhich type of surgery should become the preferred procedure for malignant pleural mesothelioma: extrapleural pneumonectomy or extended pleurectomy?Primary intrahepatic malignant mesothelioma with multiple lymphadenopathies due to non-tuberculous mycobacteria: A case report and review of the literatureGlycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma.Metastases to the oral region from pleural mesothelioma: Clinicopathologic review.Survival in Good Performance Malignant Pleural Mesothelioma Patients; Prognostic Factors and Predictors of ResponseFrequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma.Malignant pleural mesothelioma: A retrospective analysis of clinicopathological and survival data.Symptom burden in mesothelioma patients admitted to home palliative care.Pleurectomy and decortication.Expression of calretinin by breast carcinoma and the potential for misdiagnosis of mesothelioma.Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients.Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma.Evaluation of soluble mesothelin-related peptide as a diagnostic marker of malignant pleural mesothelioma effusions: its contribution to cytology.Is galectin-3 antibody a useful marker in the diagnosis of malignant pleural mesothelioma?Temporal and spatial heterogeneity of programmed cell death 1-Ligand 1 expression in malignant mesothelioma.Review of malignant pleural mesothelioma survival after talc pleurodesis or surgery.Clinical evaluation of circulating miR-548a-3p and -20a expression in malignant pleural mesothelioma patients.Pretreatment thrombocytosis as a significant prognostic factor in malignant mesothelioma: a meta-analysis.Association Between Clinicopathological Factors and Genomic Abnormalities Detected by FISH Analysis in Epithelioid Diffuse Malignant Pleural Mesothelioma.Current status of malignant mesothelioma with liver involvement in China: A brief report and review of the literature.Is there a role for prophylactic radiotherapy to intervention tract sites in patients with malignant pleural mesothelioma?
P2860
Q24607747-30B4EBFF-A67C-450B-ADEB-C0A6B8D642D1Q33630104-FBDB5EF7-2583-4ACF-8A9B-E135E5729864Q33840661-BFC4AB0A-B675-42A0-B468-0F8F96EA7435Q33871599-557CDCCF-B339-4F8D-9E26-4A9D5C9C3A11Q34036768-5ACE84B2-B3EC-4C75-A42D-44598EEC3A36Q34043710-8C7C1591-4288-452B-8420-1990CF2F33E2Q34658488-AEF6DFF5-66FE-43F6-AAAC-01A924103E50Q35172562-582188C8-5964-493D-91E3-535D2D790808Q35542880-491A190F-98CD-4AFD-9C5D-9776DD9A6626Q36328370-9BEA5310-4CC8-4D76-822D-4B2BED91E555Q36821171-5475C232-780C-425B-8EBD-DEBC3E72E068Q37128016-65A2AD08-38FA-48B9-94FF-5FC2B94CA083Q37211732-F85DE724-166D-48D8-815A-485363E2396AQ37687605-6D49ADA8-8F17-4DDD-B8EA-2CD4AD2AB682Q37956213-F107232F-AE4C-45C6-8073-E32BFC647816Q38607308-EEB7B309-C867-491C-9818-E271F32CB748Q38985236-9EFAD51C-78F2-410A-8417-FBA522433B2DQ40041012-E2741198-3D2F-4329-ABE6-8B13DEC1C585Q40618919-923D6DF6-DDA8-406A-B9BD-D80590AE90B3Q40964739-A25F0D8C-F7D8-4121-8D4E-AFA41FF7F517Q42497489-444B6D43-939D-4913-91F9-7F184A036798Q43466291-FB8F2CE0-EBEE-4264-9BE7-6AD64B1C4228Q43875251-DC28A995-FAED-48FD-89E1-F18812EAFDB9Q46122543-E96CF6AF-90E5-4F49-B475-D95414C66D47Q46858872-CD2F5B8F-D804-47A7-80E2-DCD4EE403F29Q47393402-F02E1C2E-8C55-4848-85B4-9E6549DE8AC0Q49708022-13D39B9F-C854-4E5E-862F-2FB295825447Q50102994-4C1265DB-D7BB-417A-BDE8-E30AEC9FF0C5Q54691246-C3DA696F-E71B-4E1D-8B73-3EA10DAF65D9Q54779306-87C02410-27ED-4A1D-B711-D34D4DA23C57Q54974858-9B1D6F17-73AC-4408-B299-A16F23832DCEQ59137560-461986C4-7F14-4032-88FC-1BA59DD22DA2
P2860
Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Malignant pleural mesothelioma ...... cutive series of 394 patients.
@ast
Malignant pleural mesothelioma ...... cutive series of 394 patients.
@en
Malignant pleural mesothelioma ...... cutive series of 394 patients.
@nl
type
label
Malignant pleural mesothelioma ...... cutive series of 394 patients.
@ast
Malignant pleural mesothelioma ...... cutive series of 394 patients.
@en
Malignant pleural mesothelioma ...... cutive series of 394 patients.
@nl
prefLabel
Malignant pleural mesothelioma ...... cutive series of 394 patients.
@ast
Malignant pleural mesothelioma ...... cutive series of 394 patients.
@en
Malignant pleural mesothelioma ...... cutive series of 394 patients.
@nl
P2093
P1476
Malignant pleural mesothelioma ...... ecutive series of 394 patients
@en
P2093
Alfredo Berruti
Andrea Billé
Matteo Giaj Levra
Piero Borasio
Roberto Giardino
P304
P356
10.1016/J.EJCTS.2007.09.044
P577
2008-02-01T00:00:00Z